Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein

Nicholas Trakul1, Marsha R Rosner

  • 1Ben May Institute for Cancer Research, University of Chicago, 5841 S. Maryland Avenue., Chicago, IL 60637, USA.

Cell Research
|February 3, 2005
PubMed

Insights

Raf kinase inhibitory protein (RKIP) modulates signaling pathways and protein-protein interactions, impacting cell development and cancer progression. Its role in cancer metastasis and Raf-1 activation offers potential therapeutic targets.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Cancer research

Background:

  • Proteins modulating signaling pathways, such as Raf kinase inhibitory protein (RKIP), are crucial regulators of cellular processes.
  • These modulators influence protein-protein interactions, affecting the formation of signaling complexes.
  • RKIP is implicated in both normal development and the progression of various cancers.

Purpose of the Study:

  • To investigate the role of RKIP as a regulator of signaling pathways.
  • To explore RKIP's involvement in cancer metastasis.
  • To identify the mechanism by which RKIP regulates Raf-1 activation for therapeutic potential.

Main Methods:

  • Investigated protein-protein interactions.
  • Analyzed RKIP's role in signaling complex formation.
  • Studied RKIP's impact on Raf-1 activation.

Main Results:

  • RKIP acts as a modulator of signaling pathways through protein-protein interactions.
  • RKIP is the first identified MAP kinase signaling modulator involved in cancer metastasis.
  • The mechanism of RKIP's regulation of Raf-1 activation was elucidated.

Conclusions:

  • RKIP is a highly conserved, ubiquitously expressed protein regulating multiple signaling pathways.
  • RKIP's function in growth and differentiation is vital across organisms.
  • Understanding RKIP's mechanism provides novel therapeutic targets for cancer intervention.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...